A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast Cancer von Disis, Mary L, Dang, Yushe, Coveler, Andrew L, Childs, Jennifer S, Higgins, Doreen M, Liu, Ying, Zhou, Jing, Mackay, Sean, Salazar, Lupe G

Volltext

Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer von DISIS, Mary L, WALLACE, Danelle R, DELA ROSA, Corazon, TIETJE, Kathleen, LINK, John, WAISMAN, James, SALAZAR, Lupe G, GOOLEY, Theodore A, YUSHE DANG, SLOTA, Meredith, HAILING LU, COVELER, Andrew L, CHILDS, Jennifer S, HIGGINS, Doreen M, FINTAK, Patricia A

Volltext

Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention von Corulli, Lauren R, Cecil, Denise L, Gad, Ekram, Koehnlein, Marlese, Coveler, Andrew L, Childs, Jennifer S, Lubet, Ronald A, Disis, Mary L

Volltext

Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Respons... von Cecil, Denise L, Liao, John B, Dang, Yushe, Coveler, Andrew L, Kask, Angela, Yang, Yi, Childs, Jennifer S, Higgins, Doreen M, Disis, Mary L

Volltext

Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer von Liao, John B., Jejurikar, Nikita S., Hitchcock-Bernhardt, Katie M., Gwin, William R., Reichow, Jessica L., Dang, Yushe, Childs, Jennifer S., Coveler, Andrew L., Swensen, Ron E., Goff, Barbara A., Disis, Mary L., Salazar, Lupe G.

Volltext

MOBILE TECHNOLOGIES FOR CONDUCTING, AUGMENTING AND POTENTIALLY REPLACING SURVEYS: EXECUTIVE SUMMARY OF THE AAPOR TASK FORCE ON EMERGING TECHNOLOGIES IN PUBLIC OPINION RESEARCH von LINK, MICHAEL W., MURPHY, JOE, SCHOBER, MICHAEL F., BUSKIRK, TRENT D., CHILDS, JENNIFER HUNTER, TESFAYE, CASEY LANGER

Volltext

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates von Liao, John B, Gwin, William R, Urban, Renata R, Hitchcock-Bernhardt, Katie M, Coveler, Andrew L, Higgins, Doreen M, Childs, Jennifer S, Shakalia, Hania N, Swensen, Ron E, Stanton, Sasha E, Tinker, Anna V, Wahl, Tanya A, Ancheta, Richard G, McGonigle, Kathryn F, Dai, James Y, Disis, Mary L, Goff, Barbara A

Volltext

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer von Mao, Jianning, Ladd, Jon, Gad, Ekram, Rastetter, Lauren, Johnson, Melissa M, Marzbani, Edmond, Childs, Jennifer S, Lu, Hailing, Dang, Yushe, Broussard, Elizabeth, Stanton, Sasha E, Hanash, Sam M, Disis, Mary L

Volltext

Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer von Liao, John B, Swensen, Ron E, Ovenell, Kelsie J, Hitchcock-Bernhardt, Katie M, Reichow, Jessica L, Apodaca, Minjun C, D'Amico, Leonard, Childs, Jennifer S, Higgins, Doreen M, Buening, Barbara J, Goff, Barbara A, Disis, Mary L

Volltext

HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers von Disis, Mary L., Dang, Yushe, Coveler, Andrew L., Marzbani, Edmond, Kou, Zhong C., Childs, Jennifer S., Fintak, Patricia, Higgins, Doreen M., Reichow, Jessica, Waisman, James, Salazar, Lupe G.

Volltext

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients von Stanton, Sasha E., Gad, Ekram, Ramos, Erik, Corulli, Lauren, Annis, James, Childs, Jennifer, Katayama, Hiroyuki, Hanash, Samir, Marks, Jeffrey, Disis, Mary L.

Volltext

Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity von Goodell, Vivian, Waisman, James, Salazar, Lupe G, de la Rosa, Corazon, Link, John, Coveler, Andrew L, Childs, Jennifer S, Fintak, Patricia A, Higgins, Doreen M, Disis, Mary L

Volltext

T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity von Cecil, Denise L., Park, Kyong Hwa, Gad, Ekram, Childs, Jennifer S., Higgins, Doreen M., Plymate, Stephen R., Disis, Mary L.

Volltext

Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo von Stanton, Sasha E., Eary, Janet F., Marzbani, Edmond A., Mankoff, David, Salazar, Lupe G., Higgins, Doreen, Childs, Jennifer, Reichow, Jessica, Dang, Yushe, Disis, Mary L.

Volltext

Measuring Race and Hispanic Origin: Cognitive Test Findings Searching for ‘‘Truth’’ von Hunter Childs, Jennifer, Terry, Rodney, Jurgenson, Nathan

Volltext

Tumor Antigen–Specific T-Cell Expansion Is Greatly Facilitated by In vivo Priming von YUSHE DANG, KNUTSON, Keith L, GOODELL, Vivian, DELA ROSA, Corazon, SALAZAR, Lupe G, HIGGINS, Doreen, CHILDS, Jennifer, DISIS, Mary L

Volltext

Respondent Debriefings Conducted by Experts: A Technique for Questionnaire Evaluation von Nichols, Elizabeth, Hunter Childs, Jennifer

Volltext

Final report and long-term outcomes: Phase I trial of a HER2 intracellular plasmid-based vaccine in HER2+ advanced stage breast cancer von Disis, Mary L., Dang, Yushe, Coveler, Andrew L., Higgins, Doreen, Childs, Jennifer, Salazar, Lupe G

Volltext

A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in patients with treatment refractory HER-2/neu overexpressing breast cancer von Disis, Mary L., Dang, Yushe, Coveler, Andrew L., Childs, Jennifer S, Higgins, Doreen M, Liu, Ying, Zhou, Jing, Mackay, Sean, Salazar, Lupe G.

Volltext

A phase II study of concurrent WOKVAC vaccination with neoadjuvant chemotherapy and HER2-targeted monoclonal antibody therapy von Gwin, William R, Kuano, Kristin, Childs, Jennifer, Symonds, Lynn Katherine, Coveler, Andrew L., Liao, John B., Vinayak, Shaveta, Disis, Mary L.

Volltext